The 2008 ESPEN Sir David Cuthbertson lecture: Fatty acids and inflammation - From the membrane to the nucleus and from the laboratory bench to the clinic

Clinical Nutrition

Volumn 29, Issue 1, 2010, Pages 5-12

  Calder, Philip C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cytokine; Eicosanoid; Fatty acid; Fish oil; Immune function; Inflammation; Parenteral nutrition; Sepsis; Surgery

Indexed keywords

ARACHIDONIC ACID; CYTOKINE; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DRUG MEGADOSE; ENDOTOXEMIA; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INFECTION RATE; INFLAMMATION; LENGTH OF STAY; LIPID COMPOSITION; MEDIATOR RELEASE; NONHUMAN; OXIDATIVE STRESS; PARENTERAL NUTRITION; PROSTAGLANDIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; SEPSIS; SURGICAL PATIENT; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAUMATOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL NUCLEUS; CRITICAL ILLNESS; CYTOKINES; EICOSANOIDS; EUROPE; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FISH OILS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; MEMBRANES; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATIONS; SOCIETIES, MEDICAL;

EID: 75949092130     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.11.003     Document Type: Review

References (138)

1. Cathcart E.P., Cuthbertson D.P. The composition and distribution of the fatty substances of the human subject. J Physiol 1931, 72:349-360.
2. Cuthbertson D.P. The elementary composition and caloric value of the fatty acids of the phospholipids of human skeletal muscle. Biochem J 1933, 27:1099-1102.
3. Cuthbertson D.P., Tompsett S.L. The degree of unsaturation of the fats of human adipose tissue in relation to depth from skin surface. Biochem J 1933, 27:1103-1106.
4. Cuthbertson D.P. The distribution of phosphorus and fat in the resting and fatigued muscle of the cat, with a note on the partition of phosphorus in the blood. Biochem J 1925, 19:896-910.
5. Cuthbertson D.P. The influence of prolonged muscular rest on metabolism. Biochem J 1929, 23:1328-1345.
6. Cuthbertson D.P. The disturbance of metabolism produced by bony and non-bony injury, with notes on certain abnormal conditions of the bone. Biochem J 1930, 24:1244-1263.
7. Cuthbertson D.P. The distribution of nitrogen and sulphur in the urine during conditions of increased catabolism. Biochem J 1931, 25:236-244.
8. Cuthbertson D.P. Post-shock metabolic response. Lancet 1942, i:433-437.
9. Cuthbertson D.P. Parenteral and enteral nutrition: whither the future?. Clin Nutr 1982, 1:5-23.
10. Calder P.C. Immunonutrition in surgical and critically ill patients. Br J Nutr 2007, 98:S133-S139.
11. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1997, 101:1644-1655.
12. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
13. Beutler B., Milsark I.W., Cerami A.C. Passive immunization against cachetin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985, 229:869-871.
14. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987, 330:662-664.
15. Alexander H.R., Doherty G.M., Buresh C.M., Venzon D.J., Norton J.A. A recombinant human receptor antagonist to interkeukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 1991, 173:1029-1032.
16. Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gerard C., Delvaux A., et al. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994, 24:1167-1171.
17. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinlan A., et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73:457-467.
18. Girardin E., Grau G.E., Dayer J.-M., Roux-Lombard P. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988, 319:397-400. J5 Study Group, Lambert PH.
19. Hatherill M., Tibby S.M., Turner C., Ratnavel N., Murdoch I.A. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000, 28:2591-2594.
20. Arnalich F., Garcia-Palomero E., Lopez J., Jimenez M., Madero R., Renart J., et al. Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000, 68:1942-1945.
21. Bozza F.A., Salluh J.I., Japiassu A.M., Soares M., Assis E.F., Gomes R.N., et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11:R49.
22. Vervloet M.G., Thijs L.G., Hack C.E. Derangements of coagulation and fibrinoloysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost 1998, 24:33-44.
23. 2 in immune suppression following injury. Ann Surg 1991, 214:253-263.
24. Ertel W., Morrison M.H., Meldrum D.R., Ayala A., Chaudry I.H. Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. J Surg Res 1992, 53:55-61.
25. Kollef M.H., Schuster D.P. The acute respiratory distress syndrome. N Engl J Med 1995, 332:27-37.
26. Meakins J.L., Pietsch J.B., Bubenick O., Kelly R., Rode H., Gordon J., et al. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg 1977, 186:241-250.
27. Lederer J.A., Rodrick M.L., Mannick J.A. The effects of injury on the adaptive immune response. Shock 1999, 11:153-159.
28. Oberholzer A., Oberholzer C., Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001, 16:83-96.
29. O'Sullivan S.T., Lederer J.A., Horgan A.F., Chin D.H.L., Mannick J.A., Rodrick M.L. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995, 222:482-492.
30. Heidecke C.D., Hensler T., Weighardt H., Zantl N., Wagner H., Siewert J.R., et al. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg 1999, 178:288-292.
31. Pellegrini J.D., De A.K.K., Puyana J.C., Furse R.K., Miller-Graziano C. Relationships between T lymphocyte apoptosis and anergy following trauma. J Surg Res 2000, 88:200-206.
32. Hershman M., Cheadle W., Wellhausen S., Davidson P., Polk H. Monocyte HLA-DR antigen expression characterises clinical outcome in the trauma patients. Br J Surg 1990, 77:204-207.
33. Wakefield C., Carey P., Fould S., Monson J., Guillou P. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993, 80:205-209.
34. Astiz M., Saha D., Lustbader D., Lin R., Rackow E. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J Lab Clin Med 1996, 128:594-600.
35. Manjuck J., Saha D.C., Astiz M., Eales L.-J., Rackow E.C. Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med 2000, 135:153-160.
36. Weighardt H., Heidecke C.D., Emmanuilidis K., Maier S., Bartels H., Siewert J.R., et al. Sepsis after major visceral surgery is associated with sustained and interferon-γ-resistant defects of monocyte cytokine production. Surgery 2000, 127:309-315.
37. Tschaikowsky K., Hedwig-Geissing M., Schiele A., Bremer F., Schywalsky M., Schutter J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002, 30:1015-1023.
38. Calder P.C. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 2008, 79:101-108.
39. Yaqoob P., Calder P.C. Fatty acids and immune function: new insights into mechanisms. Br J Nutr 2007, 98:S41-S45.
40. Gibney M.J., Hunter B. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 1993, 47:255-259.
41. Yaqoob P., Pala H.S., Cortina-Borja M., Newsholme E.A., Calder P.C. Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000, 30:260-274.
42. Hennig B., Toborek M., Joshi-Barve S., Barger S.W., Barve S., Mattson M.P., et al. Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. Am J Clin Nutr 1996, 63:322-328.
43. Hennig B., Meerarani P., Ramadass P., Watkins B.A., Toborek M. Fatty acid-induced activation of vascular endothelial cells. Metabolism 2000, 49:1006-1013.
44. Toborek M., Blanc E.M., Kaiser S., Mattson M.P., Hennig B. Linoleic acid potentiates TNF-mediated oxidative stress, disruption of calcium homeostasis, and apoptosis of cultured vascular endothelial cells. J Lipid Res 1997, 38:2155-2167.
45. Toborek M., Lee Y.W., Garrido R.S., Hennig B. Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am J Clin Nutr 2002, 75:119-125.
46. Young V.M., Toborek M., Yang F.J., McClain C.J., Hennig B. Effect of linoleic acid on endothelial cell inflammatory mediators. Metabolism 1998, 47:566-572.
47. Park H.J., Lee Y.W., Hennig B., Toborek M. Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kappa B-dependent pathway. Nutr Cancer 2001, 41:126-134.
48. Dichtl W., Ares M.P.S., Niemann Jonson A., Jovinge S., Pachinger O., Giachelli C.M., et al. Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kB activation. Metabolism 2002, 51:327-333.
49. Camandola S., Leonarduzzi G., Musso T., Varesio L., Carini R., Scavazza A., et al. Nuclear factor kB is activated by arachidonic acid but not by eicosapentenoic acid. Biochem Biophys Res Commun 1996, 229:643-647.
50. Priante G., Bordin L., Musacchio E., Clari G., Baggio B. Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid. Clin Sci 2002, 102:403-409.
51. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003, 100:1751-1756.
52. Bordin L., Prianti G., Musacchio E., Giunco S., Tibaldi E., Clari G., et al. Arachidonic acid-induced IL-6 expression is mediated by PKC-α activation in osteoblastic cells. Biochemistry 2003, 42:4485-4491.
53. Kinsella J.E., Lokesh B., Broughton S., Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 1990, 6:24-44.
54. Lewis R.A., Austen K.F., Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990, 323:645-655.
55. Tilley S.L., Coffman T.M., Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001, 108:15-23.
56. Calder P.C., Bevan S.J., Newsholme E.A. The inhibition of T-lymphocyte proliferation by fatty acids is via an eicosanoid-independent mechanism. Immunology 1992, 75:108-115.
57. 2 inhibits production of Th1 but not Th2 lymphokines. J Immunol 1991, 146:108-113.
58. 2 differentially modulates cytokine secretion profiles in human T-helper lymphocytes. J Immunol 1993, 150:5321-5329.
59. + T cells. J Immunol 1996, 156:1722-1727.
60. + T cells inhibits acquisition of ability to produce IFN-g and IL-2, but not IL-4 and IL-5. J Immunol 1995, 155:4604-4612.
61. Miles E.A., Aston L., Calder P.C. In vitro effects of eicosanoids derived from different 20-carbon fatty acids on T helper type 1 and T helper type 2 cytokine production in human whole-blood cultures. Clin Exp Allergy 2003, 33:624-632.
62. Calder P.C., Yaqoob P., Harvey D.J., Watts A., Newsholme E.A. The incorporation of fatty acids by lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem J 1994, 300:509-518.
63. Stulnig T.M., Zeyda M. Immunomodulation by polyunsaturated fatty acids: impact on T-cell signaling. Lipids 2004, 39:1171-1175.
64. Calder P.C., Yaqoob P. Lipid rafts - composition, characterization and controversies. J Nutr 2007, 137:545-547.
65. Shaikh S.R., Edidin M. Immunosuppressive effects of polyunsaturated fatty acids on antigen presentation by HLA class I molecules. J Lipid Res 2007, 48:127-138.
66. Sanderson P., Calder P.C. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 1998, 94:79-87.
67. Miles E.A., Calder P.C. Modulation of immune function by dietary fatty acids. Proc Nutr Soc 1998, 57:277-292.
68. Lo C.J., Chiu K.C., Fu M., Lo R., Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NFκB activity. J Surg Res 1999, 82:216-222.
69. Novak T.E., Babcock T.A., Jho D.H., Helton W.S., Espat N.J. NF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription. Am J Physiol 2003, 284:L84-L89.
70. Zhao Y., Joshi-Barve S., Barve S., Chen L.H. Eicosapentaenoic acid prevents LPS induced TNF-α expression by preventing NF-κB activation. J Am Coll Nutr 2004, 23:71-78.
71. de Caterina R., Cybulsky M.I., Clinton S.K., Gimbrone M.A., Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994, 14:1829-1836.
72. Renier G., Skamene E., de Sanctis J., Radzioch D. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice: modulation of macrophage secretory activities. Arterioscler Thromb 1993, 13:1515-1524.
73. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese J., Spur B.W., et al. Effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985, 312:1217-1224.
74. Endres S., Ghorbani R., Kelley V.E., Georgilis K., Lonnemann G., van der Meer J.M.W., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265-271.
75. Meydani S.N., Lichtenstein A.H., Cornwall S., Meydani M., Goldin B.R., Rasmussen H., et al. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. J Clin Invest 1993, 92:105-113.
76. Sperling R.I., Benincaso A.I., Knoell C.T., Larkin J.K., Austen K.F., Robinson D.R. Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993, 91:651-660.
77. von Schacky C., Kiefl R., Jendraschak E., Kaminski W.E. N-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo and in vivo. J Lab Clin Med 1993, 121:302-309.
78. Caughey G.E., Mantzioris E., Gibson R.A., Cleland L.G., James M.J. The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996, 63:116-122.
79. 2 production and T-cell function after fish-oil supplementation: response to antioxidant co-supplementation. Am J Clin Nutr 2003, 78:376-382.
80. 5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun 1983, 117:282-288.
81. Lee T.H., Mencia-Huerta J.M., Shih C., Corey E.J., Lewis R.A., Austen K.F. Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene-B5 and the double lipoxygenase product. J Biol Chem 1984, 259:2383-2389.
82. Lee T.H., Sethi T., Crea A.E., Peters W., Arm J.P., Horton C.E., et al. Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils. Clin Sci 1988, 74:467-475.
83. Serhan C.N. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004, 39:1125-1132.
84. Serhan C.N. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care 2005, 8:115-121.
85. Calder P.C., Bond J.A., Harvey D.J., Gordon S., Newsholme E.A. Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J 1990, 269:807-814.
86. Khalfoun B., Thibault F., Watier H., Bardos P., Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Biol Med 1997, 400:589-597.
87. Babcock T.A., Novak T., Ong E., Jho D.H., Helton W.S., Espat N.J. Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J Surg Res 2002, 107:135-139.
88. Billiar T.R., Bankey P.E., Svingen B.A., Curran R.D., West M.A., Holman R.T., et al. Fatty acid intake and kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 1988, 104:343-349.
89. Yaqoob P., Calder P.C. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 1995, 163:120-128.
90. Meydani S.N., Endres S., Woods M.M., Goldin B.R., Soo C., Morrill-Labrode A., et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991, 121:547-555.
91. Abbate R., Gori A.M., Martini F., Brunelli T., Filippini M., Francalanci I., et al. N-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prostaglandins Leukot Essent Fatty Acids 1996, 54:439-444.
92. Trebble T., Arden N.K., Stroud M.A., Wootton S.A., Burdge G.C., Miles E.A., et al. Inhibition of tumour necrosis factor-α and interleukin-6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr 2003, 90:405-412.
93. Wallace F.A., Miles E.A., Calder P.C. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br J Nutr 2003, 89:679-689.
94. Calder P.C. PUFA, inflammatory processes and rheumatoid arthritis. Proc Nutr Soc 2008, 67:409-418.
95. Calder P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008, 52:885-897.
96. Mascioli E.A., Leader L., Flores E., Trimbo S., Bistrian B., Blackburn G. Enhanced survival to endotoxin in guinea pigs fed iv fish oil emulsion. Lipids 1988, 23:623-625.
97. Mascioli E.A., Iwasa Y., Trimbo S., Leader L., Bistrian B.R., Blackburn G.L. Endotoxin challenge after menhaden oil diet: effects on survival of guinea pigs. Am J Clin Nutr 1989, 49:277-282.
98. Utsunomiya T., Chavali S.R., Zhong W.W., Forse R.A. Effects of continuous tube feeding of dietary fat emulsions on eicosanoid production and on fatty acid composition during an acute septic shock in rats. Biochim Biophys Acta 1994, 1214:333-339.
99. Sane S., Baba M., Kusano C., Shirao K., Andoh T., Kamada T., et al. Eicosapentaenoic acid reduces pulmonary edema in endotoxemic rats. J Surg Res 2000, 93:21-27.
100. Sadeghi S., Wallace F.A., Calder P.C. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 1999, 96:404-410.
101. Mulrooney H.M., Grimble R.F. Influence of butter and of corn, coconut and fish oils on the effects of recombinant human tumour necrosis factor-α in rats. Clin Sci 1993, 84:105-112.
102. Pomposelli J., Mascioli E.A., Bistrian B.R., Flores S.M. Attenuation of the febrile response in guinea pigs by fish oil enriched diets. J Parent Ent Nutr 1990, 13:136-140.
103. Pomposelli J.J., Flores E.A., Blackburn G., Zeisel S.H., Bistrian B.R. Diets enriched with n-3 fatty acids ameliorate lactic acidosis by improving endotoxin-induced tissue hypoperfusion in guinea pigs. Ann Surg 1991, 213:166-176.
104. Teo T.C., Selleck K.M., Wan J.M.F., Pomposelli J.J., Babayan V.K., Blackburn G.L., et al. Long-term feeding with structured lipid composed of medium-chain and n-3 fatty acids ameliorates endotoxic shock in guinea-pigs. Metabolism 1991, 40:1152-1159.
105. Murray M.J., Kanazi G., Moukabary K., Tazelaar H.D., DeMichele S.J. Effects of eicosapentaenoic and γ-linolenic acids (dietary lipids) on pulmonary surfactant composition and function during porcine endotoxemia. Chest 2000, 117:1720-1727.
106. Mancuso P., Whelan J., DeMichele S.J., Snider C.C., Guszcza J.A., Claycombe K.J., et al. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med 1997, 25:523-532.
107. Mancuso P., Whelan J., DeMichele S.J., Snider C.C., Guszcza J.A., Karlstad M.D. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoids biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med 1997, 25:1198-1206.
108. Murray M.J., Svinger B.A., Holman R.T., Yaksh T.L. Effects of a fish oil diet on pig's cardiopulmonary response to bacteremia. J Parent Ent Nutr 1991, 15:152-158.
109. Murray M.J., Svinger B.A., Yaksh T.L., Holman R.T. Effects of endotoxin on pigs prefed omega-3 vs. omega-6 fatty acids-enriched diets. Am J Physiol 1993, 265:E920-E927.
110. Murray M.J., Kumar M., Gregory T.J., Banks P.L., Tazrlaar H.D., DeMichele S.J. Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. Am J Physiol 1995, 269:H2090-H2097.
111. Pscheidl E., Schywalsky M., Tschaikowsky K., Boke-Prols T. Fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med 2000, 28:1489-1496.
112. 2 production in a rat model of chronic sepsis. J Trauma 1991, 31:768-774.
113. 2 levels and survival from group B streptococcal sepsis in neonatal rat pups. J Nutr 1997, 127:1989-1992.
114. Lanza-Jacoby S., Flynn J.T., Miller S. Parenteral supplementation with a fish oil emulsion prolongs survival and improves lymphocyte function during sepsis. Nutrition 2001, 17:112-116.
115. Johnson J.A., Griswold J.A., Muakkassa F.F., Meyer A.A., Maier R.V., Chaudry I.H., et al. Essential fatty acids influence survival in stress. J Trauma 1993, 35:128-131.
116. Calder P.C. N-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 2004, 107:1-11.
117. Burr M.L., Fehily A.M., Gilbert J.F., Rogers S., Holliday R.M., Sweetnam P.M., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2:757-761.
118. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354:447-455.
119. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897-1903. GISSI-Prevenzione Investigators.
120. Leaf A., Albert C.M., Josephson M., Steinhaus D., Kluger J., Kang J.X., et al. Fatty acid antiarrhythmia trial investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005, 112:2762-2768.
121. Thies F., Garry J.M.C., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361:477-485.
122. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
123. Calder P.C. Use of fish oil in parenteral nutrition: rationale and reality. Proc Nutr Soc 2006, 65:264-277.
124. Calder P.C. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc 2009, 68:252-260.
125. Treskova E., Carpentier Y.A., Ramakrishnan R., Al-Haideri M., Seo T., Deckelbaum R.J. Blood clearance and tissue uptake of intravenous lipid emulsions containing long-chain and medium-chain triglycerides and fish oil in a mouse model. JPEN J Parenter Enteral Nutr 1999, 23:253-257.
126. Morlion B.J., Torwesten E., Lessire A., Sturm G., Peskar B.M., Furst P., et al. The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in postoperative trauma. Metabolism 1996, 45:1208-1213.
127. Wachtler P., Konig W., Senkal M., Kemen M., Koller M. Influence of a total parenteral nutrition enriched with ω-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 1997, 42:191-198.
128. Weiss G., Meyer F., Matthies B., Pross M., Koenig W., Lippert H. Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr 2002, 87:S89-S94.
129. Schauder P., Rohn U., Schafer G., Korff G., Schenk H.-D. Impact of fish oil enriched total parenteral nutrition on DNA synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period. Br J Nutr 2001, 87:S103-S110.
130. Tsekos E., Reuter C., Stehle P., Boeden G. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr 2004, 23:325-330.
131. Wichmann M.W., Thul P., Czarnetzki H.D., Morlion B.J., Kemen M., Jauch K.W. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med 2007, 35:700-706.
132. Heller A.R., Rössler S., Litz R.J., Stehr S.N., Heller S.C., Koch R., et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006, 34:972-979.
133. Mayer K., Fegbeutel C., Hattar K., Sibelius U., Kramer H.J., Heuer K.U., et al. W-3 vs. w-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 2003, 29:1472-1481.
134. Mayer K., Gokorsch S., Fegbeutel C., Hattar K., Rosseau S., Walmrath D., et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003, 167:1321-1328.
135. Pacht E.R., DeMichele S.J., Nelson J.L., Hart J., Wennberg A.K., Gadek J.E. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 2003, 31:491-500.
136. Gadek J.E., DeMichele S.J., Karlstad M.D., Pacht E.R., Donahoe M., Albertson T.E., et al. Effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med 1999, 27:1409-1420. the Enteral Nutrition in ARDS Study Group.
137. Singer P., Theilla M., Fisher H., Gibstein L., Grozovski E., Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006, 34:1033-1038.
138. Pontes-Arruda A., Aragão A.M., Albuquerque J.D. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006, 34:2325-2333.